Atlas Trials

Study of TRDC002 in the Diagnosis of Patients With PSMA-positive Prostate Cancer

Clinical trial NCT07236112 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07236112
Sponsor
C Ray Therapeutics
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2026-02-08
Primary completion
2026-04-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.